Softgel Capsule Market Size

Softgel Capsule Market size was valued at USD 1.07 Billion in 2023 and is poised to grow from USD 1.14 Billion in 2024 to USD 1.88 Billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

Softgel capsules have a number of benefits, including ease of swallowing, odour and taste masking, better absorption, increased bioavailability, and excellent atmospheric stability. Traditional capsules now have more features thanks to improvements in manufacturing technology and the introduction of new materials, such as controlled drug release, tamper-evident packaging, and formulation choice of potent APIS due to reduced stomach pH degradation, appealing aesthetics, and longer shelf life. Manufacturers of soft gels are concentrating on creating capsules made of plant-based polymers rather than gelatine, such as starch, HPMC, and pullulan-type gums.

Vegetarians' medical needs are met by capsules free of gelatine. The main benefit of non-gelatine-based capsules is the technical advantages for producers and suppliers, as well as the decreased animal stock waste. Furthermore, the adoption of vegetable capsules by businesses like Aenova raised their sales revenue by a double-digit proportion. A chewable soft gel capsule with improved flavour masking capabilities is being developed by Euro caps. To expand their market share among the world's vegan population, other market giants like Catalent and Roquette are creating vegan capsules.

US Softgel Capsule Market is poised to grow at a sustainable CAGR for the next forecast year.